Christine Payton
Family · Marrero, LANPI 1215582309
Payments from drug & device makers
Across 260 payments — averaging $20.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$1K
- Merck$742
- Johnson & Johnson$577
- EMD Serono, Inc.$274
- Abbott$163
- plus $565 from 7 others
What the payments were for
- Travel & lodging$130%
- Food & beverage$5,22596%
- Education$2104%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 93 | $2,072 |
| Gilead | 60 | $1,056 |
| Merck | 39 | $742 |
| Johnson & Johnson(2 entities) | 32 | $577 |
| EMD Serono, Inc. | 14 | $274 |
| Abbott | 1 | $163 |
| Janssen Products, LP | 2 | $160 |
| Pfizer | 5 | $125 |
| Theratechnologies Inc. | 6 | $123 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| Lilly USA, LLC | 3 | $50 |
| Dexcom, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOVATO$369
- CABENUVA$250
- FREESTYLE LIBRE 3$163
- Biktarvy$122
How this compares
$5,448 in reported general payments places this provider in the 90th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 56 | $210,001 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 39 | $165,438 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 40 | $133,549 |
| JulucaDolutegravir/Rilpivirine | 27 | $89,209 |
| DovatoDolutegravir Sodium/Lamivudine | 19 | $54,724 |
| CabenuvaCabotegravir/Rilpivirine | 12 | $49,413 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 13 | $42,092 |
| DescovyEmtricitabine/Tenofov Alafenam | 23 | $42,065 |
| PrezcobixDarunavir/Cobicistat | 11 | $25,433 |
| TivicayDolutegravir Sodium | 11 | $16,536 |
| TrulicityDulaglutide | 13 | $12,499 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $5,999 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $455 |
| Cyproheptadine Hcl | 24 | $436 |
| Losartan Potassium | 54 | $322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $1,056 | $417,504118 claims |
| Viiv Healthcare CompanyTriumeq, Juluca, Dovato, Cabenuva, Tivicay | $2,072 | $343,432109 claims |
| Janssen Products, LPSymtuza | $160 | $42,09213 claims |
| Johnson & JohnsonPrezcobix | $577 | $25,43311 claims |
| Lilly USA, LLCTrulicity | $50 | $12,49913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,610 family providers in Louisiana.
Other family in Marrero
- Sharon JacksonMarrero$13K
- Jolie MontreuilMarrero$13K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.